4//SEC Filing
CANCER GENETICS, INC 4
Accession 0001349929-17-000038
CIK 0001349929operating
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:54 PM ET
Size
10.2 KB
Accession
0001349929-17-000038
Insider Transaction Report
Form 4
Gitelman Igor
Chief Accounting Officer
Transactions
- Sale
Common Stock, par value $0.0001 per share
2017-05-23$4.02/sh−937$3,763→ 0 total - Purchase
Common Stock, par value $0.0001 per share
2017-05-25$3.95/sh+937$3,701→ 937 total - Exercise/Conversion
Stock Option (right to buy)
2017-05-23−937→ 14,063 totalExercise: $2.50Exp: 2027-02-22→ Common Stock, par value $0.0001 per share (937 underlying) - Exercise/Conversion
Common Stock, par value $0.0001 per share
2017-05-23$2.50/sh+937$2,343→ 937 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.025 to $4.01, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]The shares underlying the option shall vest in 48 equal monthly installments commencing on the date of grant until fully vested, provided that the reporting person remains a service provider to Cancer Genetics, Inc. through each applicable vesting period.
Documents
Issuer
CANCER GENETICS, INC
CIK 0001349929
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001349929
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 4:54 PM ET
- Size
- 10.2 KB